Drug and Device Combinations: The Leadership Challenge

What are the unique human capital demands faced by Life Science companies with medical device and pharmaceutical entities? With the recent boom in the drug-coated stent market, now more than ever these companies must foster the talent necessary to keep pace with the lucrative potential of drug-device combination products. This whitepaper paper provides valuable insight into the pharma and medical device sectors and the universal leadership challenge of integrating diversified businesses.